We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Albion Development Vct Plc | LSE:AADV | London | Ordinary Share | GB0004832472 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 86.00 | 84.50 | 87.50 | 87.50 | 86.00 | 86.00 | 0.00 | 08:00:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | 8.8M | 5.75M | 0.0387 | 22.22 | 127.87M |
TIDMAADV
ALBION DEVELOPMENT VCT PLC
LEI Code 213800FDDMBD9QLHLB38
Interim Management Statement
Introduction
I present Albion Development VCT PLC (the "Company")'s interim management statement for the period from 1 July 2023 to 30 September 2023.
Performance and dividends
The Company's unaudited net asset value ("NAV") on 30 September 2023 was GBP120.13 million or 88.58 pence per share (excluding treasury shares). After accounting for the dividend of 2.29 pence per share paid on 29 September 2023 to shareholders on the register on 8 September 2023, this is a decrease of 0.88 pence per share (0.98%) since 30 June 2023.
Fundraising and share issues
During the period from 1 July 2023 to 30 September 2023, the Company issued the following shares under the dividend reinvestment scheme (and are included in the net asset value figures for 30 September 2023 above):
Number of shares Issue price per Net invested Date issued share GBP'000 ------------------ ------------------ ------------------ ------------------ 29 September 2023 567,025 89.46p 488 ------------------ ------------------ ------------------ ------------------
The Company announced on 12 October 2023 that, subject to obtaining the requisite regulatory approval, it intended to launch a prospectus top up offer of new ordinary shares. Full details of the Offer will be contained in a prospectus that is expected to be published prior to launch in early January 2024.
Portfolio
The following investments have been made during the period from 1 July 2023 to 30 September 2023:
New investments GBP000s Activity ---------------------- ------- ------------------------------ Phasecraft 418 Software for Quantum Computers ---------------------- ------- ------------------------------ Kennek 171 Vertical software for lenders ---------------------- ------- ------------------------------ Total new investments 589 ---------------------- ------- ------------------------------ Further investments GBP000s Activity --------------- ------- ---------------------------------------------------- Gravitee 568 API management platform --------------- ------- ---------------------------------------------------- A middleware technology platform that enables life science organisations to conduct medical research uMed 391 programmes --------------- ------- ---------------------------------------------------- Data extraction and analytics technology for private Accelex 89 capital markets --------------- ------- ---------------------------------------------------- Total further investments 1,048 --------------- ------- ----------------------------------------------------
Top ten holdings (on 30 September 2023)
% of net Portfolio Carrying value asset Company GBP000s value Activity ------------- -------------- ----- ------------------------------------------------------------ Quantexa 24,958 20.8 Network analytics platform to detect financial crime ------------- -------------- ----- ------------------------------------------------------------ Proveca 9,131 7.6 Reformulation of medicines for children ------------- -------------- ----- ------------------------------------------------------------ Egress Software Technologies 8,890 7.4 Encrypted email & file transfer service provider ------------- -------------- ----- ------------------------------------------------------------ A technology enabled service business in medical nutritional Oviva 4,424 3.7 therapy (MNT) ------------- -------------- ----- ------------------------------------------------------------ Radnor House School (TopCo) 3,552 3.0 Independent school for children aged 2-18 ------------- -------------- ----- ------------------------------------------------------------ The Evewell Operator and developer of women's health centres focusing Group 2,618 2.2 on fertility ------------- -------------- ----- ------------------------------------------------------------ Chonais River Owner and operator of a 2 MW hydro-power scheme in Hydro 2,288 1.9 the Scottish Highlands ------------- -------------- ----- ------------------------------------------------------------ The Street by Street Solar Owner and operator of photovoltaic systems on domestic Programme 2,199 1.8 properties in the UK ------------- -------------- ----- ------------------------------------------------------------ Convertr Media 1,872 1.6 Digital lead generation software ------------- -------------- ----- ------------------------------------------------------------ Regenerco 1,804 1.5 Generator of renewable energy from roof top solar Renewable installations Energy ------------- -------------- ----- ------------------------------------------------------------
A full breakdown of the Company's portfolio can be found on the Company's webpage on the Manager's website at https://www.globenewswire.com/Tracker?data=pIj9XtTx0Tor9ei-zgpLqzV0yWPVyd4otBIUYQ-I4EnJVyyGH_zKqdfOV09rxyNL1EH4bQMZBeTdNoYN4zv51RpZlOeHJVnSSITPxeexxMGUMArmF2u_x2ebAmBsSefU www.albion.capital/funds/AADV.
Share buy-backs
During the period from 1 July 2023 to 30 September 2023, the Company purchased 533,338 shares for GBP456,000 (including stamp duty) at a price of 84.99 pence per share. All of the shares are to be held in treasury.
It remains the Board's policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company's interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders.
It is the Board's intention for such buy-backs to be at around a 5% discount to net asset value, so far as market conditions and liquidity permit.
Material events and transactions after the period end
-- As announced on 6 October 2023, the Company sold a proportion of its holding in Quantexa at its current holding value returning proceeds of GBP2.7m; and -- As announced on 30 October 2023, following a formal tender process, Johnston Carmichael LLP were appointed the Company's Auditor.
There have been no other material events or transactions after the period end to the date of this announcement.
Further information
Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company's webpage on the Manager's website at https://www.globenewswire.com/Tracker?data=pIj9XtTx0Tor9ei-zgpLqzV0yWPVyd4otBIUYQ-I4EndGOHQNuITtnMBrYt-pZyq6I880c3b2MUPSlY1B8rfDfcYAaEGP-3uk5QSpwKzJ8BqgfXyUlEvmN9LLKELNF9h www.albion.capital/funds/AADV.
Ben Larkin, Chairman
20 November 2023
For further information please contact:
Vikash Hansrani
Operations Partner
Albion Capital Group LLP
Telephone: 020 7601 1850
(END) Dow Jones Newswires
November 20, 2023 07:15 ET (12:15 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Albion Development Vct Chart |
1 Month Albion Development Vct Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions